Scope 1, 2, and 3 greenhouse gas (GHG) emissions
The company has an opportunity to disclose reductions in Scope 1 and 2 and Scope 3 greenhouse gas emissions, and set time-bound targets aligned with the Paris agreement’s 1.5 degree pathway.
Antibiotic use and growth promoting substances
The company has an opportunity to disclose a policy on reducing the (prophylactic) use of antibiotics and/or growth promoting substances. Additionally, it can disclose targets to phase out the prophylactic use of antibiotics across all species, geographies, and products and report the progress against these targets.
Ecosystem conversion
The company has an opportunity to disclose its efforts to avoid ecosystem conversion, including deforestation or restoration. The company could develop a strategy and publicly report on specific, time-bound targets.
Food loss and waste
The company has an opportunity to disclose its food loss and waste (FLW) reduction targets and report progress against these targets. Additionally, the company can consider aligning its FLW reduction goal with SDG12.3, which aims for a 50% reduction by 2030.
Plastic use and packaging waste
The company has an opportunity to disclose quantitative evidence regarding plastic use reduction and use of sustainable packaging.
Soil health and agrobiodiversity
The company has an opportunity to disclose activities and targets to improve soil health or agrobiodiversity in its production or sourcing practices, and report progress against them.
Water withdrawal
The company has multiple opportunities to enhance its sustainability efforts related to water withdrawal. It can start by disclosing quantitative evidence of reductions in water withdrawal across its own operations. Additionally, the company can set a time-bound target to reduce water withdrawal across its own operations and regularly report progress in achieving this target. Furthermore, engaging with suppliers to reduce water withdrawal presents another opportunity for the company to make a positive impact in this area.